Hims & Hers Health has announced the acquisition of Zava, a prominent European digital health firm, with plans to close the transaction in late 2025. This move could exponentially increase Hims' customer reach from 2.4 million in the U.S. to more across Europe, tapping into Zava's existing user base of 1.3 million. The expansion into Europe is timed well, given the region’s more affordable pharmaceutical pricing compared to the U.S., which may lead to wider accessibility of telehealth services as consumer demand grows for personalized healthcare solutions.
The demand for simpler, more personalized healthcare is universal," said Andrew Dudum, founder and CEO of Hims & Hers, in a press release. "By leveraging Zava's established European presence, cutting-edge technology, and deep customer understanding, we're poised to fundamentally transform access to care for millions across Europe.
The medications are priced more competitively than in the U.S. so more people can actually afford it and we are seeing a huge demand," said Zava CEO David Meinertz in an interview with CNBC. "The demand is increasing with additional strains on the statutory systems that telehealth can alleviate.
Collection
[
|
...
]